Which statement describes the purpose of keeping essential documents post-trial?

Which statement describes the purpose of keeping essential documents post-trial?

• A. Documentation for audit and regulatory review.
• B. To show sponsor involvement.
• C. For marketing.
• D. For future trials only.

Answer: (A)

Keeping essential documents after a trial is about ensuring an auditable record for regulatory review. These documents provide a clear trail of how the study was planned, conducted, and monitored—showing approvals, informed consent, protocol adherence, data handling, and safety reporting. Regulators and sponsors rely on this documentation to reconstruct the study, verify compliance with the protocol and ICH GCP, and assess the safety and integrity of the data during inspections or audits. While some documents may be useful for informing future trials, the primary purpose is to support audits and regulatory oversight, not marketing or merely demonstrating sponsor involvement. Retention is therefore tied to regulatory review requirements and approved retention periods, not just the intent to use them for future studies.

Keeping essential documents after a trial is about ensuring an auditable record for regulatory review. These documents provide a clear trail of how the study was planned, conducted, and monitored—showing approvals, informed consent, protocol adherence, data handling, and safety reporting. Regulators and sponsors rely on this documentation to reconstruct the study, verify compliance with the protocol and ICH GCP, and assess the safety and integrity of the data during inspections or audits. While some documents may be useful for informing future trials, the primary purpose is to support audits and regulatory oversight, not marketing or merely demonstrating sponsor involvement. Retention is therefore tied to regulatory review requirements and approved retention periods, not just the intent to use them for future studies.